Today: 16 April 2026
Standard Chartered (STAN.L) stock slips as buyback and 2025 targets come into focus
7 January 2026
1 min read

Standard Chartered (STAN.L) stock slips as buyback and 2025 targets come into focus

London, Jan 7, 2026, 09:38 GMT — Regular session

• Shares fall about 1.8% in London trade, easing from recent highs
• Bank restates 2025 income and profitability targets in a Q4 update note
• Investors weigh buyback support against macro nerves ahead of key U.S. labour data

Standard Chartered PLC (STAN.L) shares fell 1.8% to 1,804 pence by mid-morning trade in London on Wednesday. Other UK lenders were also weaker, with NatWest Group down 2.6% and HSBC off 0.6%. Standard Chartered traded between 1,801 and 1,834.5 pence, after a recent 52-week high of 1,875.5 pence.

The move comes a day after the bank published a note summarising key messages from its fourth-quarter 2025 investor and conference appearances, keeping its core targets unchanged. Standard Chartered said it was tracking “towards the upper end” of its 5–7% income growth range for 2025 at constant currency — stripping out foreign-exchange swings — and guided to roughly 13% RoTE, or return on tangible equity, a key profitability measure. Chief executive Bill Winters flagged “a bit of slowdown” in the fourth quarter after a “exceptionally strong” third quarter, while the bank kept its full-year results date for Feb. 24.

Standard Chartered also disclosed fresh share repurchases, a support investors have leaned on as the stock has rallied. The lender said it bought 530,530 shares on Jan. 6 at prices ranging from 1,845.5 to 1,872 pence, and plans to cancel them, reducing the share count. The bank put the average at 1,855.83 pence using a volume-weighted average price (VWAP), which weights each trade by size.

The broader backdrop has turned more cautious after a sharp start to the year in London equities. The FTSE 100 surged through the 10,000-point mark on Tuesday, setting fresh highs as investors rotated into heavyweight sectors.

Macro jitters also crept back in after a sharp drop in oil prices, and as traders positioned for U.S. labour-market updates that can shift rate bets. Michael McCarthy, CEO of investment platform Moomoo Australia and New Zealand, said the latest Venezuela oil developments “most likely” support global growth, but the uncertainty around supply can still “overwhelm the benefit.” Markets were awaiting the JOLTS job-openings report later on Wednesday and the U.S. monthly employment report on Friday.

For Standard Chartered, investors are now weighing how far buybacks and reiterated targets can steady the stock after a steep run. Traders will also look for any new colour on costs, credit losses and fee growth when the bank reports full-year numbers.

But the stock’s climb has narrowed the margin for error. A softer-than-expected fourth quarter, or a sharp shift in rate expectations after U.S. data, could test sentiment even if the buyback continues.

Stock Market Today

  • Amerigo Resources Q1 2026 Results Signal Capital Allocation Shift with Dividend and Buyback
    April 15, 2026, 9:21 PM EDT. Amerigo Resources Ltd. (TSX:ARG) reported Q1 2026 operating results reaffirming full-year copper and molybdenum production guidance. The company completed a C$5.9 million share buyback and declared a C$0.16 per-share performance dividend payable in May 2026. Despite scheduled maintenance, cash costs trended below guidance, highlighting operational efficiency. Amerigo's single-asset strategy focuses on cash generation and capital returns, underscored by this combination of buyback and special dividend. Shares have risen but appear undervalued by roughly 30% against fair value estimates ranging from C$5.26 to C$9.15. However, recent insider selling adds risk. The firm's capital discipline and market positioning suggest investors watch copper prices, MVC execution, and future capital decisions closely.

Latest article

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
NatWest share price drops after Barclays downgrade as buybacks and earnings come into focus
Previous Story

NatWest share price drops after Barclays downgrade as buybacks and earnings come into focus

Intuitive Surgical stock jumps as investors eye JPM healthcare conference and Jan. 22 earnings
Next Story

Intuitive Surgical stock jumps as investors eye JPM healthcare conference and Jan. 22 earnings

Go toTop